NCT02512718View on ClinicalTrials.gov

Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 18, 2023

Study Completion Date

May 18, 2023

Conditions
Hematopoietic Stem Cell Transplantation
Interventions
DRUG

Omegaven

Comparison of FOLE vs. SOLE

DRUG

Soybean oil lipid emulsion

Comparison of FOLE vs. SOLE

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Alexandra N. Carey

OTHER

NCT02512718 - Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter